← Eichor
Study identifier: NCT07466108 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Hemodynamic Effects of Intravenous Paracetamol in Patients Undergoing Emergency Laparotomy

Condition: Paracetamol · Hypotension Drug-Induced · Emergency Surgery  ·  Sponsor: Cairo University

PhaseNA
Planned participants90
Who can joinAll sexes, 21 Years to 65 Years
Healthy volunteersNo

About this study

Emergency laparotomy is a high-risk procedure often performed in patients with severe physiological derangements due to sepsis, making perioperative management challenging. Although multimodal analgesia is essential, options are often limited by factors such as hemodynamic instability, renal dysfunction, and coagulopathy. Intravenous paracetamol is commonly recommended for perioperative analgesia because of its opioid-sparing effect, but evidence suggests it may cause hypotension through peripheral vasodilation, particularly in critically ill patients. Most data on this effect come from observational studies, and evidence regarding its intraoperative hemodynamic impact remains limited.

This description comes directly from the study's public registry record.

Talk to the study team

Maha Mostafa  ·  +201000365115  ·  maha.mostafa@cu.edu.eg

Always discuss trial participation with your own doctor first.

Locations (1)

Cairo UniversityCairo, Cairo Governorate, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07466108